Tibet Cheezheng Tibetan Medicine Co., Ltd.

Tibet Cheezheng Tibetan Medicine Co., Ltd. has seen a rise in its stock price, contrasting with a decline in the broader market. The company, operating in the Pharmaceuticals & Biotechnology sector, has a market capitalization of CNY 11,523 million and offers a dividend yield of 2.75%.

Tibet Cheezheng Tibetan Medicine Co., Ltd. saw a significant rise in its stock today, contrasting with the broader market's performance. However, the company has struggled over the past year, with minimal returns and declines in both monthly and year-to-date performance, despite a stable market capitalization and dividend yield.

Tibet Cheezheng Tibetan Medicine Co., Ltd. saw its stock price decline significantly, contrasting with the broader market's performance. Over the past week and month, the company has faced notable decreases, attributed to rising raw material costs and a low dividend payout ratio, impacting its overall market standing.

Tibet Cheezheng Tibetan Medicine Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. The company has faced challenges, including rising raw material costs and a low dividend payout ratio, contributing to its underperformance over various timeframes in the pharmaceuticals sector.

Tibet Cheezheng Tibetan Medicine Co., Ltd. saw a decline in its stock price, contrasting with the broader market's performance. The company has faced challenges in growth, with modest increases in net sales and operating profit over five years, while raw material costs have significantly risen. Its market capitalization stands at CNY 13,732 million.